Distinctive Neuroanatomical Substrates for Depression in Bipolar Disorder versus Major Depressive Disorder.


Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 22 04 2017
accepted: 02 11 2017
pubmed: 5 12 2017
medline: 4 3 2020
entrez: 5 12 2017
Statut: ppublish

Résumé

No neuroanatomical substrates for distinguishing between depression of bipolar disorder (dBD) and major depressive disorder (dMDD) are currently known. The aim of the current multicenter study was to identify neuroanatomical patterns distinct to depressed patients with the two disorders. Further analysis was conducted on an independent sample to enable generalization of results. We directly compared MR images of these subjects using voxel-based morphometry (VBM) and a support vector machine (SVM) algorithm using 1531 participants. The VBM analysis showed significantly reduced gray matter volumes in the bilateral dorsolateral prefrontal (DLPFC) and anterior cingulate cortices (ACC) in patients with dBD compared with those with dMDD. Patients with the two disorders shared small gray matter volumes for the right ACC and left inferior frontal gyrus when compared with healthy subjects. Voxel signals in these regions during SVM analysis contributed to an accurate classification of the two diagnoses. The VBM and SVM results in the second cohort also supported these results. The current findings provide new evidence that gray matter volumes in the DLPFC and ACC are core regions in displaying shared and distinct neuroanatomical substrates and can shed light on elucidation of neural mechanism for depression within the bipolar/major depressive disorder continuum.

Identifiants

pubmed: 29202177
pii: 4653730
doi: 10.1093/cercor/bhx319
pmc: PMC6294408
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-214

Références

J Affect Disord. 2009 Jun;115(3):395-410
pubmed: 19019455
Neuroimage. 2008 Feb 1;39(3):1180-5
pubmed: 18032068
J Affect Disord. 2016 Jan 15;190:744-753
pubmed: 26606718
J Affect Disord. 2005 Feb;84(2-3):117-25
pubmed: 15708408
Psychiatry Res. 2017 Feb;248:127-133
pubmed: 28040657
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 1;1(2):186-194
pubmed: 27047994
Biol Psychiatry. 2001 May 1;49(9):741-52
pubmed: 11331082
Biol Psychiatry. 2013 Jan 15;73(2):111-8
pubmed: 22784485
Eur Psychiatry. 2017 Jan;39:17-26
pubmed: 27810614
Mol Psychiatry. 2008 Sep;13(9):829, 833-57
pubmed: 18574483
Brain. 2015 Nov;138(Pt 11):3440-8
pubmed: 26373602
Acta Psychiatr Scand. 2010 Dec;122(6):507-15
pubmed: 20712826
Mol Psychiatry. 2012 Apr;17(4):412-20
pubmed: 21321565
Psychiatry Res. 2013 Jan 30;211(1):37-46
pubmed: 23146253
J Affect Disord. 2013 Apr 25;146(3):414-9
pubmed: 23017544
Mol Psychiatry. 2017 Oct;22(10):1455-1463
pubmed: 27217146
J Clin Psychiatry. 2010 Jan;71(1):26-31
pubmed: 19646366
Neuroimage. 2008 Aug 15;42(2):611-6
pubmed: 18585930
Arch Gen Psychiatry. 2011 Jul;68(7):675-90
pubmed: 21727252
World J Biol Psychiatry. 2013 Jul;14(5):334-85
pubmed: 23879318
Biol Psychiatry. 2008 Apr 1;63(7):656-62
pubmed: 17949689
Neuroimage. 2014 Jan 1;84:299-306
pubmed: 24004694
Neuropsychopharmacology. 2010 Jan;35(1):192-216
pubmed: 19693001
Bipolar Disord. 2011 Feb;13(1):28-40
pubmed: 21320250
Schizophr Res. 2010 Mar;117(1):1-12
pubmed: 20071149
Neuropsychologia. 2010 May;48(6):1862-8
pubmed: 20176041
Neurosci Bull. 2015 Feb;31(1):4-12
pubmed: 25502401
Bipolar Disord. 2008 Feb;10(1 Pt 2):144-52
pubmed: 18199233
Bipolar Disord. 2014 Jun;16(4):378-88
pubmed: 24428430
JAMA Psychiatry. 2016 Jun 1;73(6):557-64
pubmed: 27145449
J Clin Psychiatry. 2003 Feb;64(2):161-74
pubmed: 12633125
Depress Anxiety. 2015 Dec;32(12):871-91
pubmed: 26382227
Mol Psychiatry. 2008 Nov;13(11):993-1000
pubmed: 18504424
Psychol Med. 2014 Feb;44(3):519-32
pubmed: 23734914
JAMA Psychiatry. 2014 Nov;71(11):1222-30
pubmed: 25188810
Hum Brain Mapp. 2008 Jun;29(6):683-95
pubmed: 17598168
Hum Brain Mapp. 2014 May;35(5):1865-74
pubmed: 23723177
CNS Spectr. 2006 Apr;11(4):312-20; quiz 323-4
pubmed: 16641836
Am J Psychiatry. 2004 Apr;161(4):598-607
pubmed: 15056502
J Affect Disord. 2012 Apr;138(1-2):9-18
pubmed: 21511342
Trends Cogn Sci. 2012 Jan;16(1):61-71
pubmed: 22197477
Neurosci Biobehav Rev. 2014 May;42:132-47
pubmed: 24603026
Biol Psychiatry. 1999 May 1;45(9):1085-98
pubmed: 10331101
Biol Psychiatry. 2010 Jun 1;67(11):1097-105
pubmed: 20303066
Mol Psychiatry. 2013 May;18(5):528-39
pubmed: 23546169
Am J Psychiatry. 2008 Mar;165(3):313-20
pubmed: 18245175
Hum Brain Mapp. 2010 Jul;31(7):943-57
pubmed: 19862698
Am J Psychiatry. 2004 Nov;161(11):1957-66
pubmed: 15514393
Br J Psychiatry. 2013 Sep;203(3):310-1
pubmed: 23969484
Bipolar Disord. 2012 Mar;14(2):135-45
pubmed: 22420589
Schizophr Res. 2008 Apr;101(1-3):95-105
pubmed: 18378428
Mol Psychiatry. 2015 May;20(5):609-14
pubmed: 25092248
Hum Brain Mapp. 2009 Nov;30(11):3719-35
pubmed: 19441021
Bipolar Disord. 2009 Jun;11(4):361-70
pubmed: 19500089
JAMA Psychiatry. 2014 Apr;71(4):388-96
pubmed: 24522197
Biol Psychiatry. 2007 Jul 1;62(1):7-16
pubmed: 17240360
Am J Psychiatry. 2008 Mar;165(3):370-7; quiz 410
pubmed: 18198271
PLoS One. 2016 Dec 28;11(12):e0168493
pubmed: 28030612
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95
pubmed: 16677749
Bipolar Disord. 2013 Feb;15(1):1-44
pubmed: 23237061
J Affect Disord. 2011 Dec;135(1-3):139-47
pubmed: 21807414
Arch Gen Psychiatry. 2008 Sep;65(9):1017-32
pubmed: 18762588

Auteurs

Koji Matsuo (K)

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, Japan.

Kenichiro Harada (K)

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, Japan.

Yusuke Fujita (Y)

Division of Electrical, Electronic and Information Engineering, Graduate School of Sciences and Technology for Innovation, Yamaguchi University, Tokiwadai 2-16-1, Ube, Yamaguchi, Japan.

Yasumasa Okamoto (Y)

Department of Psychiatry and Neurosciences, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Miho Ota (M)

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, Japan.

Hisashi Narita (H)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, Japan.

Benson Mwangi (B)

Department of Psychiatry, The University of Texas Health Science Center at Houston, TX, USA.

Carlos A Gutierrez (CA)

Department of Psychiatry, The University of Texas Health Science Center at Houston, TX, USA.

Go Okada (G)

Department of Psychiatry and Neurosciences, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Masahiro Takamura (M)

Department of Psychiatry and Neurosciences, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Hirotaka Yamagata (H)

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, Japan.

Ichiro Kusumi (I)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, Japan.

Hiroshi Kunugi (H)

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, Japan.

Takeshi Inoue (T)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, Japan.
Department of Psychiatry, Tokyo Medical University, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo, Japan.

Jair C Soares (JC)

Department of Psychiatry, The University of Texas Health Science Center at Houston, TX, USA.

Shigeto Yamawaki (S)

Department of Psychiatry and Neurosciences, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Yoshifumi Watanabe (Y)

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH